Clobot클로봇

Clobot is growing revenue quickly but still loses money, and its share price has fallen sharply over the past year.

Clobot, a Korean robotics software and robot services company listed on KOSDAQ since October 2024, reported trailing twelve-month revenue of ₩45.6B through H1 2026 alongside an operating loss of ₩3.3B. Its share price is ₩18,940, down 51.2% over one year and near its 52-week low of ₩18,030. The company holds ₩22.2B in cash against ₩1.0B in borrowings, and its latest filings include an equity acquisition decision and several insider and 5%+ holding reports.

What stands out

• Revenue rose about 24% in 2025 to ₩41.4B, but the operating loss narrowed only modestly from ₩7.5B in 2024 to ₩3.2B in 2025.
• Trailing twelve-month net margin is -7.5% and free cash flow is -₩3.2B, so the business is not yet self-funding.
• Valuation is high for a loss-making company, with a price-to-book ratio of 10.2 and price-to-sales of 12.9; P/E is not meaningful because earnings are negative. Dividend yield is 0%.
• Foreign ownership rose to 6.6% from 5.7% over about 60 days, while foreign and institutional investors were net sellers over the last 20 days and retail investors were net buyers.
• Recent news centres on the company's ambition to become a global top-5 robot solution company, expanding into logistics and humanoid robots; the data does not include details on how this would be achieved.

What to watch

• The amended material matters report on an equity acquisition from August 31, 2026, including its size and purpose, which the data does not describe.
• The next periodic results, to check whether the operating loss keeps narrowing and free cash flow turns positive.
• Further 5%+ holding and insider shareholding reports, given recent insider filings and the sharp share price decline.